Evaluating CMR

Metabolic Syndrome and Type 2 Diabetes/CVD Risk


Key Points

Page: Go to Previous Page 1 of 9 Go to Next Page

  • Waist girth is a mandatory feature of International IDF clinical criteria for diagnosing the metabolic syndrome.
  • For the first time, population-specific cut-offs have been proposed to consider ethnic differences in the relationship between abdominal obesity and incidence of CHD and type 2 diabetes.
  • IDF clinical criteria are similar to those proposed by the NCEP-ATP III regarding metabolic markers used to diagnose the metabolic syndrome.
  • When managing the metabolic syndrome, the first step should be to reduce intra-abdominal (visceral) adipose tissue through lifestyle modification.
  • Most prospective studies have found a positive relationship between the metabolic syndrome (IDF criteria) and CVD.
  • Further research is required to establish specific waist circumference cut-offs for all regions of the world.